Suppr超能文献

新型基质金属蛋白酶 12 选择性放射性示踪剂用于血管分子成像。

Novel Matrix Metalloproteinase 12 Selective Radiotracers for Vascular Molecular Imaging.

机构信息

Cardiovascular Molecular Imaging Laboratory, Section of Cardiovascular Medicine and Yale Cardiovascular Research Center , Yale University School of Medicine , New Haven , Connecticut 06511 , United States.

Veterans Affairs Connecticut Healthcare System , West Haven , Connecticut 06516 , United States.

出版信息

J Med Chem. 2019 Nov 14;62(21):9743-9752. doi: 10.1021/acs.jmedchem.9b01186. Epub 2019 Oct 25.

Abstract

Matrix metalloproteinase-12 (MMP-12) is highly upregulated in several inflammatory diseases, including abdominal aortic aneurysm (AAA). Here we report four novel Tc-labeled radiotracers derived from a highly selective competitive MMP-12 inhibitor. These tracers in their Tc version were assessed in vitro on a set of human metalloproteases and displayed high affinity and selectivity toward MMP-12. Their radiolabeling with Tc was shown to be efficient and stable in both buffer and mouse blood. The tracers showed major differences in their biodistribution and blood clearance. On the basis of its in vivo performance, [Tc]- was selected for evaluation in murine AAA, where MMP-12 gene expression is upregulated. Autoradiography of aortae at 2 h postinjection revealed high uptake of [Tc]- in AAA relative to adjacent aorta. Tracer uptake specificity was demonstrated through in vivo competition. This study paves the way for further evaluation of [Tc]- for imaging AAA and other MMP-12-associated diseases.

摘要

基质金属蛋白酶-12(MMP-12)在几种炎症性疾病中高度上调,包括腹主动脉瘤(AAA)。在这里,我们报告了四种源自高度选择性竞争 MMP-12 抑制剂的新型 Tc 标记放射性示踪剂。这些示踪剂在其 Tc 版本中在一组人类金属蛋白酶上进行了评估,表现出对 MMP-12 的高亲和力和选择性。在缓冲液和小鼠血液中,它们的 Tc 标记均显示出高效和稳定。示踪剂在其生物分布和血液清除方面存在显着差异。基于其体内性能,[Tc]-被选择用于 MMP-12 基因表达上调的小鼠 AAA 的评估。注射后 2 小时的主动脉自动放射显影显示 [Tc]-在 AAA 中的摄取明显高于相邻的主动脉。通过体内竞争证明了示踪剂摄取的特异性。这项研究为进一步评估 [Tc]-用于成像 AAA 和其他 MMP-12 相关疾病铺平了道路。

相似文献

1
Novel Matrix Metalloproteinase 12 Selective Radiotracers for Vascular Molecular Imaging.
J Med Chem. 2019 Nov 14;62(21):9743-9752. doi: 10.1021/acs.jmedchem.9b01186. Epub 2019 Oct 25.
2
Preclinical Evaluation of RYM1, a Matrix Metalloproteinase-Targeted Tracer for Imaging Aneurysm.
J Nucl Med. 2017 Aug;58(8):1318-1323. doi: 10.2967/jnumed.116.188656. Epub 2017 Mar 30.
3
Hydroxamate-Based Selective Macrophage Elastase (MMP-12) Inhibitors and Radiotracers for Molecular Imaging.
J Med Chem. 2020 Dec 10;63(23):15037-15049. doi: 10.1021/acs.jmedchem.0c01514. Epub 2020 Nov 18.
5
Positron Emission Tomography Imaging of Vessel Wall Matrix Metalloproteinase Activity in Abdominal Aortic Aneurysm.
Circ Cardiovasc Imaging. 2023 Jan;16(1):e014615. doi: 10.1161/CIRCIMAGING.122.014615. Epub 2023 Jan 17.
6
99mTc-labeled small-molecule inhibitors of prostate-specific membrane antigen for molecular imaging of prostate cancer.
J Nucl Med. 2013 Aug;54(8):1369-76. doi: 10.2967/jnumed.112.116624. Epub 2013 Jun 3.
7
Synthesis and in Vitro and in Vivo Evaluation of MMP-12 Selective Optical Probes.
Bioconjug Chem. 2016 Oct 19;27(10):2407-2417. doi: 10.1021/acs.bioconjchem.6b00377. Epub 2016 Sep 14.
9
Novel Tc(III) Complexes [TcCl(CDO)(CDOH)B-R] (CDOH = Cyclohexanedione Dioxime) Useful as Radiotracers for Heart Imaging.
Bioconjug Chem. 2016 Nov 16;27(11):2770-2779. doi: 10.1021/acs.bioconjchem.6b00552. Epub 2016 Oct 24.
10
Kit formulated asialoglycoprotein receptor targeting tracer based on copolymer for liver SPECT imaging.
Nucl Med Biol. 2014 Aug;41(7):587-93. doi: 10.1016/j.nucmedbio.2014.04.005. Epub 2014 Apr 12.

引用本文的文献

1
Homeostatic, Non-Canonical Role of Macrophage Elastase in Vascular Integrity.
Circ Res. 2023 Feb 17;132(4):432-448. doi: 10.1161/CIRCRESAHA.122.322096. Epub 2023 Jan 24.
2
Molecular Imaging of Matrix Metalloproteinase-2 in Atherosclerosis Using a Smart Multifunctional PET/MRI Nanoparticle.
Int J Nanomedicine. 2022 Dec 28;17:6773-6789. doi: 10.2147/IJN.S385679. eCollection 2022.
3
Phosphinic Peptides as Tool Compounds for the Study of Pharmacologically Relevant Zn-Metalloproteases.
ACS Pharmacol Transl Sci. 2022 Nov 28;5(12):1228-1253. doi: 10.1021/acsptsci.2c00183. eCollection 2022 Dec 9.
4
Radiopharmaceuticals for PET and SPECT Imaging: A Literature Review over the Last Decade.
Int J Mol Sci. 2022 Apr 30;23(9):5023. doi: 10.3390/ijms23095023.
5
In Vivo Imaging of Biodegradable Implants and Related Tissue Biomarkers.
Polymers (Basel). 2021 Jul 17;13(14):2348. doi: 10.3390/polym13142348.
6
Mechanisms of Proteolytic Enzymes and Their Inhibition in QM/MM Studies.
Int J Mol Sci. 2021 Mar 22;22(6):3232. doi: 10.3390/ijms22063232.
7
Evaluation of cardiac allograft vasculopathy by positron emission tomography.
J Nucl Cardiol. 2021 Dec;28(6):2616-2628. doi: 10.1007/s12350-020-02438-0. Epub 2021 Jan 3.
8
Hydroxamate-Based Selective Macrophage Elastase (MMP-12) Inhibitors and Radiotracers for Molecular Imaging.
J Med Chem. 2020 Dec 10;63(23):15037-15049. doi: 10.1021/acs.jmedchem.0c01514. Epub 2020 Nov 18.
9
Current and novel radiopharmaceuticals for imaging cardiovascular inflammation.
Q J Nucl Med Mol Imaging. 2020 Mar;64(1):4-20. doi: 10.23736/S1824-4785.20.03230-6. Epub 2020 Feb 18.

本文引用的文献

1
Novel Arginine-containing Macrocyclic MMP Inhibitors: Synthesis, Tc-labeling, and Evaluation.
Sci Rep. 2018 Aug 3;8(1):11647. doi: 10.1038/s41598-018-29941-2.
4
Matrix metalloproteinase 12 promotes tumor propagation in the lung.
J Thorac Cardiovasc Surg. 2018 May;155(5):2164-2175.e1. doi: 10.1016/j.jtcvs.2017.11.110. Epub 2018 Feb 21.
6
Synthesis of radioiodinated probes targeted toward matrix metalloproteinase-12.
Bioorg Med Chem Lett. 2018 Jan 15;28(2):193-195. doi: 10.1016/j.bmcl.2017.11.027. Epub 2017 Nov 17.
7
Recent opportunities in matrix metalloproteinase inhibitor drug design for cancer.
Expert Opin Drug Discov. 2018 Jan;13(1):75-87. doi: 10.1080/17460441.2018.1398732. Epub 2017 Oct 31.
8
Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders.
Prog Mol Biol Transl Sci. 2017;148:355-420. doi: 10.1016/bs.pmbts.2017.04.003. Epub 2017 May 10.
9
Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.
Biochim Biophys Acta Mol Cell Res. 2017 Nov;1864(11 Pt A):1927-1939. doi: 10.1016/j.bbamcr.2017.06.009. Epub 2017 Jun 19.
10
Therapeutic Potential of Matrix Metalloproteinase Inhibition in Breast Cancer.
J Cell Biochem. 2017 Nov;118(11):3531-3548. doi: 10.1002/jcb.26185. Epub 2017 Jul 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验